Tag: Baylis Medical

First Commercial Use of Baylis Medical Technologies’ PowerWire® Pro for In-Stent Restenosis

MISSISSAUGA, ON, June 5, 2024 /PRNewswire/ – Baylis Medical Technologies today announced the completion of its first clinical use of the PowerWire® Pro Radiofrequency (RF) Guidewire to safely cross a chronically occluded peripheral stent.

Continue Reading

Photograph of Dr. Iafrati and his team holding up a PowerWire® Pro box after their successful case. (CNW Group/Baylis Medical Technologies Inc.)

The procedure was performed in April 2024, by Mark Iafrati, MD, Professor of Vascular Surgery in Nashville, TN. The patient was suffering from a chronically occluded stent that extended from the inferior vena cava (IVC) down to the left common iliac vein. Previous attempts to cross the occlusion with mechanical tools were unsuccessful, likely owing to the dense fibrotic nature of the occlusion. The patient was brought back and Dr. Iafrati performed the procedure with the PowerWire Pro RF Guidewire, which utilizes RF energy to vaporize a channel through occlusions, allowing for successful crossing and subsequent revascularization of the iliocaval stent. 

“This marks a significant advancement in the treatment of patients with in-stent restenosis”, commented Dr. Iafrati. “I was able to easily cross the occluded stents with the PowerWire Pro RF Guidewire when my standard tools had failed.”
This spring, the FDA cleared Baylis Medical Technologies’ PowerWire Pro RF Guidewire, a device designed to cross occluded peripheral vessels, including those with stents, using radiofrequency technology.Frank Baylis, Executive Chairman of Baylis Medical Technologies, expressed enthusiasm about the PowerWire® Pro RF Guidewire’s potential impact, stating, “This innovation aims to simplify the often challenging and time-consuming process of crossing chronic occlusions in revascularization procedures, ensuring uninterrupted patient treatment.”
About Baylis Medical Technologies Inc.
Baylis Medical Technologies seeks to improve the lives of patients through the conception and commercialization of state-of-the-art medical devices. The company proudly carries forward Gloria Baylis’ legacy to enhance access to care through its divisions of Endovascular and Design and Manufacturing Services. Baylis Medical Technologies’ clinical solutions are utilized by healthcare professionals worldwide to improve patient outcomes for individuals with cardiovascular and other medical conditions. Learn more about our innovative products and ongoing mission at www.baylismedtech.com.For any inquiries, please contact [email protected] or call 1-888-505-4885

PRM-00910 J-1 V-1 © Baylis Medical Technologies Inc., 2024. PowerWire is a trademark and/or registered trademark of Baylis Medical Technologies Inc. in the United States and other countries. Baylis Medical Technologies Inc. reserves the right to change specifications or to incorporate design changes without notice and without incurring any obligation relating to equipment previously manufactured or delivered. Patents Pending and/or issued. CAUTION: Federal Law (USA) restricts the sale of these devices to or by the order of a physician. Before use, consult product labels and inserts for any indications, contraindications, hazards, warnings, cautions and instructions for use.

SOURCE Baylis Medical Technologies Inc.

Boston Scientific Closes Acquisition of Baylis Medical Company Inc.

MARLBOROUGH, Mass., Feb. 15, 2022 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Baylis Medical Company Inc., a company that offers advanced transseptal access solutions as well as guidewires, sheaths and dilators used to support catheter-based left-heart procedures. “The close of this acquisition allows Boston Scientific to integrate the Baylis platforms with our existing […]

Boston Scientific Corporation to acquire Baylis Medical Company

Baylis Medical Technologies to increase investment in radiology and neurosurgery business in Canada MISSISSAUGA, Ont. (October 6, 2021) – Baylis Medical Company Inc. is pleased to announce it has reached an agreement to sell its cardiology business to Boston Scientific Corporation. The acquisition, for an upfront payment of $1.75 billion USD, subject to closing adjustments, […]

Baylis Medical Announces First Clinical Case Using the VersaCross® Large Access Solution in Canada

TORONTO, Aug. 25, 2021 /PRNewswire/ – Baylis Medical announced today the first clinical use of the VersaCross® Large Access Solution in Canada, to perform a Left Atrial Appendage Closure (LAAC) procedure. The new solution includes the world’s first 3-in-1 radiofrequency (RF) wire paired with a seamless shapeable dilator designed to optimize tissue dilation for large sheath procedures including […]

CINDE announces: Baylis Medical Opens MedTech Facility in Costa Rica

Headquartered in Canada, the company will manufacture in Costa Rica cardiovascular products to serve global markets. The 2.800 mts2 facility will be in La Lima Free Zone. CARTAGO, Costa Rica, Aug. 3, 2021  /PRNewswire/ — Baylis Medical, a Canadian company and leader in the development and commercialization of innovative medical devices in cardiology, announced today its arrival in Costa Rica. The company […]

Mentice receives order of total SEK 5.9 million from Baylis Medical Company

STOCKHOLM, June 30, 2021 /PRNewswire/ — Mentice AB (publ) a leading supplier of high-technology solutions for simulation in the medical sector with focus on interventional procedures, has entered into an agreement with Baylis Medical Company (“Baylis”) to provide simulation solutions. Based on this order, Mentice will support Baylis’ product portfolio for transseptal puncture procedures with Mentice systems to be delivered in […]

2-French Electrophysiology Microcatheter Launches in Europe, Enabling Deeper Coronary Sinus Mapping

TORONTO, Jan. 19, 2021 /PRNewswire/ — Baylis Medical announced today the launch and first clinical case in Europe of the JLL 2-French electrophysiology microcatheter, performed by Dr. Thomas Deneke at Heart Center, Bad Neustadt, Germany. The launch enables physicians to reach previously inaccessible areas of the heart for procedure mapping, by making available the smallest diagnostic catheter in the European electrophysiology market. The JLL […]

Baylis Medical Launches 2-French Electrophysiology Catheter in Canada for Deeper Coronary Sinus Mapping

TORONTO, Dec. 15, 2020 /CNW/ – Baylis Medical announced today the Canadian launch of its EPstar Electrophysiology Catheters. The launch enables physicians to reach previously inaccessible areas of the heart for procedure mapping, by making available the smallest diagnostic catheter in the Canadian electrophysiology market. The EPstar catheter family includes a 2F catheter and a 6F guiding catheter which can […]

Study Finds TMVR Procedural Efficiency with use of the VersaCross® RF Transseptal Solution

MitraClip™ Guide delivery achieved in under 7.5 minutes1 TORONTO, Dec. 1, 2020 /PRNewswire/ – A recent publication demonstrated procedural efficiency for MitraClip™ transcatheter mitral valve repair (TMVR) with use of the VersaCross® RF Transseptal Solution, reporting guide delivery from femoral access in under 7.5 minutes1. The VersaCross solution features a single radiofrequency (RF)-tipped wire used to introduce the transseptal sheath into the superior vena cava (SVC), gain transseptal access and act […]

Baylis Medical Announces First Clinical Use of the All-in-One VersaCross® Steerable Solution

TORONTO, Sept. 1, 2020 /PRNewswire/ – Baylis Medical announced today the first clinical use of the VersaCross Steerable Access Solution, performed at the University of California, San Francisco (UCSF). The newest addition to the VersaCross Transseptal Platform combines the VersaCross RF wire with a steerable sheath, making it the ultimate, all-in-one solution to enable radiofrequency (RF) ablation procedures. Launched […]